Skip to main content
Equibles

Massar Capital Management, LP

Position in HROW — Harrow, Inc.

CIK 2037238 STAMFORD, CT
Back to HROW Full portfolio

Position in HROW

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$217,021
-$228,453 QoQ
Shares Held
5,110
-59.6% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#156
of 224 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HROW Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Massar Capital Management, LP holds $8,768,387 across 6 Drug Manufacturers - Specialty & Generic names. HROW ranks #5 (2.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 8,055 $4,364,440
2 LQDA
Liquidia Corp
 27,797 $2,216,254
3 ALKS
Alkermes plc.
 26,010 $1,362,924
4 ZTS
Zoetis Inc.
 8,175 $587,455
5 HROW
Harrow, Inc.
This page 		5,110 $217,021
6 AKBA
Akebia Therapeutics, Inc.
 17,801 $20,293

All Filings in HROW

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $217,021 5,110
2026-03-31 $445,474 12,634